Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population
NCT00614302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 428
Last updated 2009-10-02
Summary
Data collection for better patient characterization in a highly treatment experienced population. Studying the clinical practice for the treatment of HIV multiexperienced patients in the real life.
The research will be divided into two phases:
* The first phase intends to define and understand the clinical practice using a questionnaire about general topics: definitions of multiexperienced patients and VL failure, therapeutic strategies and behaviour in particular cases.
* The second part of the research will collect the clinical data of double PIs failure patients.
Conditions
- HIV Infections
Interventions
- DRUG
-
TPV
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Boehringer Ingelheim · Boehringer Ingelheim
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2008-10-31
Countries
- Italy
Study Locations
More Related Trials
-
Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.
NCT04098315 ·Status: RECRUITING
-
Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir
NCT06640192 ·Status: RECRUITING ·Phase: PHASE2
-
Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
NCT01813292 ·Status: COMPLETED
-
Establishment of a Database of HIV Subjects Initiating or Simplifying Dual Therapy With Dolutegravir/Lamivudine
NCT06637813 ·Status: NOT_YET_RECRUITING
-
Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection
NCT01297127 ·Status: COMPLETED
-
Observational, Retrospective, Multicenter Study to Describe the Reasons for the Change of the Regimen of Antiretroviral Therapy in HIV Patients
NCT02039921 ·Status: COMPLETED
-
Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
NCT00062660 ·Status: APPROVED_FOR_MARKETING
-
Bitherapy With the Combination of Raltegravir and Darunavir (BIRDi)
NCT03348449 ·Status: COMPLETED
-
Immuno-virological Evaluation of Persons Living With HIV (PLWH)
NCT05973825 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF
NCT02121795 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Cohort of HIV/HBV-coinfected Patients in Europe
NCT04984772 ·Status: ENROLLING_BY_INVITATION
-
Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen
NCT02191332 ·Status: COMPLETED
-
Prospective HIV Chemotherapy Cohort Study
NCT01902693 ·Status: COMPLETED
-
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
NCT04311944 ·Status: UNKNOWN ·Phase: NA
-
Observational Study of Treated and Untreated Acute and Early HIV-1 Infection
NCT00219934 ·Status: COMPLETED
-
Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)
NCT02926456 ·Status: COMPLETED
-
Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults
NCT01968551 ·Status: COMPLETED ·Phase: PHASE3
-
Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).
NCT04225325 ·Status: UNKNOWN ·Phase: PHASE4
-
Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)
NCT00615563 ·Status: COMPLETED
-
Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
NCT01475838 ·Status: COMPLETED ·Phase: PHASE3
-
Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort
NCT06107140 ·Status: COMPLETED
-
An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection
NCT01902615 ·Status: COMPLETED
-
Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years
NCT02616783 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Raltegravir in a Large Urban HIV Clinical Population in Milan
NCT01467349 ·Status: COMPLETED
-
Observational Study With Antiretroviral Treated Patients Switching to Nevirapine Plus Two Nucleoside Reverse Transcriptase Inhibitor (NRTI) Regimens
NCT02191319 ·Status: COMPLETED